Gastric peroral endoscopic myotomy outcomes after 4 years of follow-up in a large cohort of patients with refractory gastroparesis (with video)

Published:April 01, 2022DOI:https://doi.org/10.1016/j.gie.2022.03.025

      Background and Aims

      Gastric peroral endoscopic myotomy (G-POEM) is used for refractory gastroparesis (RG) with good early-term but variable mid- and long-term outcomes. Limited data exist about candidates and long-term clinical and predictive factors. Our aim was to evaluate the 4-year follow-up efficacy and predictive factors in patients with RG.

      Methods

      Confirmed RG patients were included and evaluated between April 2017 and December 2021. Gastroparesis Cardinal Symptom Index (GCSI) score, retention percentage at 4 hours (RP4H), mean half-emptying time (MHET), and the 36-item short-form survey (SF-36) were performed at 1, 6, 12, 18, 24, 30, 36, 42, and 48 months.

      Results

      After G-POEM, 374 patients with RG were included: 141 patients (37.7%) had diabetic gastroparesis (DG), 115 (30.7%) had idiopathic gastroparesis (IG), 102 (27.3%) had postsurgical gastroparesis (PSG), and 16 (4.3%) had other etiologies. After the 48-month evaluation, 102 patients completed follow-up (DG, 58; IG, 22; PSG, 18; other, 4). Before G-POEM, GCSI score, RP4H, and MHET were 3.84 ± .53, 44% (interquartile range [IQR], 11-68), and 246 minutes (IQR, 150-368), respectively, and after the 48-month evaluation improved to 2.1 ± .70 (P < .001), 15.5% (IQR, 0-36; P = .021), and 135 minutes (IQR, 67-290; P = .045), respectively. At the 48-month evaluation, clinical success was 77.5%. DG showed the best outcomes (DG vs IG vs PSG vs other: 86.5% vs 72.5% [P = .001] vs 72.1% [P = .003] vs 68.8% [P < .001]). Long-term success predictors were DG (odds ratio [OR], 5.113; 95% confidence interval [CI], 1.643-5.981; P = .035), early diagnosis (OR, 2.455; 95% CI, 1.129-3.522; P = .042), nausea/vomiting (OR, 3.541; 95% CI, 1.881-5.511; P = .012), GCSI score at 6 months (1.5-2) (OR, 3.612; 95% CI, 2.122-5.317; P = .022), and RP4H <10% at 6 months (OR, 2.188; 95% CI, 1.435-4.233; P = .039).

      Conclusions

      G-POEM is an effective 4-year treatment in patients with RG, especially in DG, establishing a potential first-line therapy in these patients. However, randomized controlled clinical trials are needed to confirm these results. (Clinical trial registration number: NTC03126513.)

      Abbreviations:

      CI (confidence interval), CS (clinical success), DG (diabetic gastroparesis), GCSI (Gastric Cardinal Symptom Index), GES (gastric-emptying scintigraphy), G-POEM (gastric peroral endoscopic myotomy), IG (idiopathic gastroparesis), IQR (interquartile range), MHET (mean half-emptying time), OR (odds ratio), PSG (postsurgical gastroparesis), RG (refractory gastroparesis), RP4H (retention percentage at 4 hours), SF-36 (36-item short-form survey)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Canjemi D.
        • Lacy B.
        Gastroparesis.
        Curr Opin Gastroenterol. 2021; 37: 596-601
        • Schol J.
        • Wauters L.
        • Dickman R.
        • et al.
        United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.
        United Eur Gastroenterol J. 2020; 9: 287-306
        • Tack J.
        • Camilleri M.
        New developments in the treatment of gastroparesis and functional dyspepsia.
        Curr Opin Pharmacol. 2018; 43: 111-117
        • Cherian D.
        • Parkman H.P.
        Nausea and vomiting in diabetic and idiopathic gastroparesis.
        Neurogastroenterol Motil. 2012; 24: 217-222
        • Vijayvargiya P.
        • Jameie-Oskooei S.
        • Camilleri M.
        • et al.
        Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and metaanalysis.
        Gut. 2019; 68: 804-813
        • Parkman H.P.
        • Yates K.
        • Hasler W.L.
        • et al.
        Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity.
        Gastroenterology. 2011; 140: 101-115
        • Wadhwa V.
        • Mehta D.
        • Jobanputra Y.
        • et al.
        Healthcare utilization and costs associated with gastroparesis World.
        J Gastroenterol. 2017; 23: 4428-4436
        • Oh J.H.
        • Pasricha P.J.
        Recent advances in the pathophysiology and treatment of gastroparesis.
        Neurogastroenterol Motil. 2013; 19: 18-24
        • Mearin F.
        Pyloric dysfunction in diabetics with recurrent nausea and vomiting.
        Gastroenterology. 1986; 90: 1919-1925
        • Uemura K.L.
        • Chaves D.
        • Bernardo W.M.
        • et al.
        Peroral endoscopic pyloromyotomy for gastroparesis: a systematic review and meta-analysis.
        Endosc Int Open. 2020; 8: E911-E923
        • Weusten B.
        • Barret M.
        • Bredenoord A.J.
        • et al.
        Endoscopic management of gastrointestinal motility disorders—part 1: European Society of Gastrointestinal Endoscopy (ESGE) guideline.
        Endoscopy. 2020; 52: 498-515
        • Rao A.S.
        • Camilleri M.
        Review article: metoclopramide and tardive dyskinesia.
        Aliment Pharmacol Ther. 2010; 31: 11-19
        • Camilleri M.
        • Parkman H.P.
        • Shafi M.A.
        • et al.
        Clinical guideline: management of gastroparesis.
        Am J Gastroenterol. 2013; 108: 18-37
        • Khashab M.A.
        • Besharati S.
        • Ngamruengphong S.
        • et al.
        Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video).
        Gastrointest Endosc. 2015; 82: 1106-1109
        • McCallum R.
        • Lin Z.
        • Wetzel P.
        • et al.
        Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis.
        Clin Gastroenterol Hepatol. 2005; 3: 49-54
        • Khashab M.A.
        • Stein E.
        • Clarke J.O.
        • et al.
        Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video).
        Gastrointest Endosc. 2013; 78: 764-768
        • Kahaleh M.
        • Gonzalez J.M.
        • Xu M.M.
        • et al.
        Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a multicenter international experience.
        Endoscopy. 2018; 50: 1053-1058
        • Khashab M.A.
        • Ngamruengphong S.
        • Carr-Locke D.
        • et al.
        Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video).
        Gastrointest Endosc. 2016; 85: 123-128
        • Shlomovitz E.
        • Pescarus R.
        • Cassera M.A.
        • et al.
        Early human experience with per-oral endoscopic pyloromyotomy (POP).
        Surg Endosc. 2014; 29: 543-551
        • Vosoughi K.
        • Ichkhanian Y.
        • Benia P.
        • et al.
        Gastric per-oral endoscopic myotomy (G-POEM) for refractgory gastroparesis: results from an international prospective trial.
        Gut. 2022; 71: 25-33
        • Spadaccini M.
        • Maselli R.
        • Chandrasekar V.T.
        • et al.
        Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis. A systematic review of early outcomes with pooled analysis.
        Gastrointest Endosc. 2021; 91: 746-752
        • Gregor L.
        • Wo J.
        • DeWitt J.
        • et al.
        Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a prospective single-center experience with mid-term follow-up (with video).
        Gastrointest Endosc. 2021; 94: 35-44
        • Gonzalez J.M.
        • Benezech A.
        • Vitton V.
        • et al.
        G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome.
        Aliment Pharmacol Ther. 2017; 46: 364-370
        • Xu J.
        • Chen T.
        • Elkholy S.
        • et al.
        Gastric peroral endoscopic myotomy (G-POEM) as a treatment for refractory gastroparesis: long-term outcomes.
        Can J Gastroenterol Hepatol. 2018; 6409698: 1-10
        • Ragi O.
        • Jacques J.
        • Branche J.
        One-year result of gastric peroral endoscopic myotomy for refractory gastroparesis. A French multicenter study.
        Endoscopy. 2021; 53: 480-490
        • Abdelfatah M.
        • Noll A.
        • Kapil N.
        • et al.
        Long-term outcome of gastric per-oral endoscopic pyloromyotomy in treatment of gastroparesis.
        Clin Gastroenterol Hepatol. 2021; 19: 816-824
        • Revicki D.A.
        • Rentz A.M.
        • Dubois D.
        • et al.
        Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
        Qual Life Res. 2004; 13: 833-844
        • Abell T.L.
        • Camilleri M.
        • Donohoe K.
        • et al.
        American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.
        Am J Gastroenterol. 2008; 103: 753-763
        • Ware Jr., J.E.
        • Sherbourne C.D.
        The MOS 36-item short-form health survey (SF-36). I.Conceptual framework and item selection.
        Med Care. 1992; 30: 473-483
        • Mekaroonkamol P.
        • Dacha S.
        • Wang L.
        • et al.
        Gastric peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces Health case use for patients with gastroparesis.
        Clin Gastroenterol Hepatol. 2019; 17: 82-89
        • Cotton P.B.
        • Eisen G.M.
        • Aabakken L.
        • et al.
        A lexicon for endoscopic adverse events: report of an ASGE workshop.
        Gastrointest Endosc. 2010; 71: 446-454
        • Moraveji S.
        • Bashashati M.
        • Elhanafi S.
        • et al.
        Depleted interstitial cells of Cajal and fibrosis in the pylorus: Novel features of gastroparesis.
        Neurogastroenterol Motil. 2016; 28: 1048-1054
        • Grover M.
        • Farrugia G.
        • Lurken M.S.
        • et al.
        Cellular changes in diabetic and idiopathic gastroparesis.
        Gastroenterology. 2011; 140: 1575-1585
        • Gonlachanvit S.
        • Maurer A.
        • Fisher R.
        • et al.
        Regional gastric emptying abnormalities in functional dyspepsia and gastro-oesophageal reflux disease.
        Neurogastroenterol Motil. 2006; 18: 894-904
        • Mekaroonkamol P.
        • Patel V.
        • Shah R.
        • et al.
        Association between duration or etiology of gastroparesis and clinical response after gastric per-oral endoscopic pyloromyotomy.
        Gastrointest Endosc. 2019; 89: 969-976
        • Pasricha P.J.
        Future directions in the treatment of gastroparesis.
        Gastroenterol Clin North Am. 2015; 44: 185-189
        • Jacques J.
        • Pagnon L.
        • Hure F.
        • et al.
        Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function.
        Endoscopy. 2018; 51: 40-49
        • Gourcerol G.
        • Tissier F.
        • Melchior C.
        • et al.
        Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation.
        Aliment Pharmacol Ther. 2015; 41: 360-367
        • Desprez C.
        • Chambaz M.
        • Melchior C.
        • et al.
        Assessment of pyloric sphincter distensibility and pressure in patients with diabetic gastroparesis.
        Neurogastroenterol Motil. 2021; 33: e14064

      Linked Article